Altria, Johnson & Johnson, Waste Management, TJX, Linde, Costco and Quest Diagnostics add defense to a portfolio, scoring highest among S&P 500 stocks on an antifragility screen of low volatility, strong free cash flow, minimal debt and stable earnings. All are also trending up this year, with momentum scores above 75; Altria scores 100 on antifragility and J&J 99. x.com 

Big Tobacco remains attractive because scale lowers unit costs and nicotine substitution can shift consumption beyond cigarettes. Cigarettes are homogeneous, so volume lowers costs; Sweden's shift to snus and nicotine pouches shows where consumption can move. The screen ranks tobacco among the strongest subsectors on fundamentals and market pricing. x.com  x.com  x.com  x.com 

Starbucks still carries a premium valuation even as coffee competition intensifies nationwide, so betting against it is reasonable. Coffee is habitual and generates good cash returns, but barriers to entry are low: deep-pocketed, PE-backed 7 Brew and regional chains like Summermoon and Foxtail are scaling aggressively. @CreditCapi's short case adds that store closures inflated Starbucks' same-store sales growth by 483 bps and that competitor openings cut its traffic 8-10%. x.com 

Consumer staples such as Costco, Walmart, Procter & Gamble, Kroger, General Mills, Coca-Cola and PepsiCo are among the names to study if hantavirus fear dominates the next 60-90 days, whether or not a lockdown happens. Markets react to perception before confirmed reality, and fear alone shifts attention, behavior and capital flows. A real pandemic is not needed; the fear narrative only has to persist long enough for capital and behavior to start shifting. x.com 

Large-cap value stocks should do well as the Fed starts a hiking cycle; BofA favors them because they have historically outperformed at this stage, and analysts expect three more hikes over 12 months. The US mega-caps with the highest Deep Value Scores, combining low multiples with high free-cash-flow yields, are Verizon 88, CVS Health 86, Pfizer 84, AT&T 84, Bristol Myers Squibb 82, ConocoPhillips 74, T-Mobile 74, Chevron 72, Altria 70 and Exxon Mobil 65. x.com 

Costco, Apple, Intuitive Surgical, Alphabet and MSCI are amazing companies priced too high for their growth. Costco trades at 46x earnings on high-single-digit growth, Apple at 32x forward on low-double-digit EPS growth, and Intuitive Surgical at 38x forward on low-teens growth. Alphabet, the most attractive, is 33x operating income excluding investment gains. MSCI is 34x trailing on low-double-digit growth; S&P Global is better, cheaper and extremely high quality with similar growth. x.com  … Show more

Scared money is flowing into Costco as a flight to safety, driving a box breakout. It may not be the best choice, but fearful buyers are not being selective right now. x.com 

Ten proven non-tech businesses with durable advantages and long compounding records can beat the S&P 500 over five years at lower risk. Eli Lilly has huge diabetes and obesity franchises; Costco has membership revenue and loyalty; Walmart adds higher-margin e-commerce and ads; JPMorgan is arguably the strongest US bank; Caterpillar and Brookfield ride infrastructure and AI capital needs; O'Reilly and AutoZone pair steady earnings with buybacks; American Express and Berkshire compound reliably. … Show more

Developments around Altria's on! nicotine pouch brand look unfavorable, with new flavors coming in Q4 for on! Plus. x.com 

These 12 stocks are quality compounders sharing pricing power, recurring demand, strong returns on capital and disciplined management. Domino's earns royalties, AutoZone serves an aging fleet, Progressive underwrites with data, Waste Management owns routes and landfills, Grainger is embedded in operations, S&P Global and FICO are mission-critical, Rollins has recurring pest control, Copart an auction network, Visa a fee network, HEICO niche aerospace parts, Costco loyal members. x.com  x.com  … Show more